"Isolate Id","Study","Species","Organism Group","Country","State","Gender","Age Group","Speciality","Source","In / Out Patient","Year","Phenotype","MIC","breakpoint","Drug"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"1","Susceptible","Amikacin"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,"1","Susceptible","Amikacin"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"1","Susceptible","Cefepime"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,"32","Resistant","Cefepime"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"2","Susceptible","Ceftazidime"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,">16","Resistant","Ceftazidime"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"8","Susceptible","Ceftriaxone"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,">32","Resistant","Ceftriaxone"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"0.12","Susceptible","Levofloxacin"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,"0.06","Susceptible","Levofloxacin"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"0.25","Susceptible","Meropenem"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,"0.25","Susceptible","Meropenem"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"<=0.5","Susceptible","Minocycline"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,"<=0.5","Susceptible","Minocycline"
"1456577","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Abscess / Pus","Inpatient","2016",NA,"0.25","Susceptible","Piperacillin tazobactam"
"1689621","TEST","Acinetobacter baylyi","Non-Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Surgery General","Bodily Fluids: Bile","Inpatient","2017",NA,">128","Resistant","Piperacillin tazobactam"
